Casirivimab + Imdevimab Prevents Progression to Symptomatic COVID-19

  • Meagan P. O'Brien

Press/Media

Period26 Jan 2022

Media coverage

2

Media coverage

  • TitleCasirivimab + Imdevimab Prevents Progression to Symptomatic COVID-19
    Media name/outletThe Breeze: James Madison University
    Country/TerritoryUnited States
    Date26/01/22
    PersonsMeagan P. O'Brien
  • TitleCasirivimab + Imdevimab Prevents Progression to Symptomatic COVID-19
    Media name/outletThe Griffon News: Missouri Western State College
    Country/TerritoryUnited States
    Date26/01/22
    PersonsMeagan P. O'Brien